Long non-coding RNAs as promising biomarkers and therapeutic targets in cervical cancer

Cervical cancer is the second most common cancer in women. The detection of oncopathologies in the early stages of development is a paramount task of modern medicine, which can be solved only by improving modern diagnostic methods. The use of screening for certain tumor markers could complement mode...

Full description

Saved in:
Bibliographic Details
Published inNon-coding RNA research Vol. 8; no. 2; pp. 233 - 239
Main Authors Begliarzade, Sema, Beilerli, Aferin, Sufianov, Albert, Tamrazov, Rasim, Kudriashov, Valentin, Ilyasova, Tatiana, Liang, Yanchao, Beylerli, Ozal
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.06.2023
KeAi Publishing
KeAi Communications Co., Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cervical cancer is the second most common cancer in women. The detection of oncopathologies in the early stages of development is a paramount task of modern medicine, which can be solved only by improving modern diagnostic methods. The use of screening for certain tumor markers could complement modern tests such as testing for oncogenic types of human papillomavirus (HPV), cytology, colposcopy with acetic acid and iodine solutions. Such highly informative biomarkers can be long noncoding RNAs (lncRNAs) that are highly specific compared to the mRNA profile and are involved in the regulation of gene expression. LncRNAs are a class of non-coding RNAs molecules that are typically over 200 nucleotides in length. LncRNAs may be involved in the regulation of all major cellular processes, including proliferation and differentiation, metabolism, signaling pathways, and apoptosis. LncRNAs molecules are highly stable due to their small size, which is also their undoubted advantage. The study of individual lncRNAs as regulators of the expression of genes involved in the mechanisms of oncogenesis cervical cancer can be not only of great diagnostic value, but, as a result, of therapeutic significance in cervical cancer patients. This review article will present the characteristics of lncRNAs that allow them to be used as accurate diagnostic and prognostic tools, as well as to consider them as effective therapeutic targets in cervical cancer.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2468-0540
2468-0540
DOI:10.1016/j.ncrna.2023.02.006